Director Culverwell bought 100,000 shares of QNRX at $0.45; holds 100,317 post-transaction (+31545.7% vs prior). Cluster buy.
Anthony James Culverwell, a Director at Quoin Pharmaceuticals, purchased 100,000 shares at $0.45 on 2024-12-23, expanding his position from 317 shares to 100,317 shares—a 31545.7% increase. The stock now trades at $19.25, down -89.3% from its 52-week high of $180.14, and has declined -8.2% over the past 30 days despite a 90-day positive return of +7.0%. This acquisition occurs within a broader cluster pattern: 3 other insiders also purchased shares within the past 14 days. While the company reported a full-year net income of $-2.3M (unprofitable), the coordinated insider activity across multiple directors during a period of significant price depreciation from the 52-week high warrants close examination of the underlying drivers and any material developments that may not yet be fully reflected in current pricing.